Alzheimer's amyloid β-peptide (1-42): Involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide

Neurobiology of Aging

Volumn 25, Issue 5, 2004, Pages 563-568

  Butterfield, D Allan ^a   Bush, Ashley I ^b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Amyloid; Methionine; Neurotoxicity; Oxidative stress; peptide

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; FREE RADICAL; LIPID; METHIONINE; OXYGEN; PEPTIDE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BRAIN SYNAPTOSOME; HUMAN; LIPID PEROXIDATION; NEUROPATHOLOGY; NEUROTOXICITY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS;

EID: 1842519391     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.12.027     Document Type: Article

References (50)

1. Abe K., Matsuki N. Measurement of cellular 3-(4, 5-dimethylthiazol-2-yl)- 2, 5-diphenyltetrazolium bromide (MTT) reduction activity and la dehydrogenase release using MTT. Neurosci. Res. 38:2000;325-329
2. Barnham K.J., Ciccotosto G.D., Tickler A.K., Ali F.E., Smith D.G., Williams Lam Y.H., et al. Neurotoxic, redox-competent Alzheimer's (beta)-amyloid Is from lipid membrane by methionine oxidation. J. Biol. Chem. 278:2003;42959-42965
3. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G., Teplow D.B. Amyloid β-protein (Aβ) assembly: Aβ40 and A4β2 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. U.S.A. 100:2003;330-335
4. 35 and amyloid β-protein oligomerization. J Am Chem Soc. 125:2003;15359-15365
5. Butterfield D.A., Stadtman E.R. Protein oxidation processes in aging brain. Adv. Cell Aging Gerontol. 2:1997;161-191
6. Butterfield D.A., Drake J., Pocernich C., Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role of amyloid β-peptide. Trends Molec. Med. 7:2001;548-554
7. Butterfield D.A., Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32:2002;1050-1060
8. Butterfield D.A., Castegna A., Lauderback C.M., Drake J. Review: evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contributes to neuronal death. Neurobiol. Aging. 23:2002;655-664
9. Butterfield D.A., Kanski J. Review: methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid β-peptide 1-42. Peptides. 23:2002;1299-1309
10. Butterfield D.A., Boyd-Kimball D., Castegna A. Proteomics in Alzheimer's disease: insights into mechanisms of neurodegeneration. J Neurochem. 86:2003;1313-1327
11. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J.B., Pierce W.M., et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I. Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med. 33:2002;562-571
12. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J.B., Pierce W.M., et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II. Dihydropyrimidinase-related protein 2, α-enolase, and heat shock cognate 71. J. Neurochem. 82:2002;1524-1532
13. Castegna A., Thongboonkerd V., Klein J.B., Lynn B., Markesbery W.R., Butterfield D.A. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J. Neurochem. 85:2003;1394-1401
14. Coles M., Bicknell W., Watson A.A., Fairlie D.P., Craik D.J. Solution structure of amyloid β-peptide(1-40) in a water-micelle environment Is the membrane-spanning domain where we think it is? Biochemistry. 37:1998;11064-11077
15. Curtain C.C., Ali F., Volitakis I., Cherny R.A., Norton R.S., Beyrether K., et al. Alzheimer's disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 276:2001;20466-20473
16. Dickey C.A., Loring J.F., Montgomery J., Gordon M.N., Eastman P.S., Morgan D. Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor + presenilin-1 transgenic mice. J. Neurosci. 23:2003;5219-5226
17. Dong J., Atwood C.S., Anderson V.E., Siedlak S.L., Smith M.A., Perry G., et al. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry. 42:2003;2768-2773
18. Drake J., Link C.D., Butterfield D.A. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol. Aging. 24:2003;415-420
19. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde, and related aldehydes. Free Rad. Biol. Med. 11:1991;81-128
20. Gabbita S.P., Aksenov M.Y., Lovell M.A., Markesbery W.R. Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J. Neurochem. 73:1999;1660-1666
21. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., et al. Alzheimer's disease-affected brain: presence of oligomeric aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. USA. 100:2003;10417-10422
22. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156
23. Hou L., Kang I., Marchant R.E., Zagorski M.G. Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease. J. Biol. Chem. 277:2002;40173-40176
24. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scarpa R.C., et al. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 38:1999;7609-7616
25. Kanski J., Aksenova M., Schoneich C., Butterfield D.A. Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer's amyloid β-peptide (1-42). Free Radic. Biol. Med. 32:2002;1205-1211
26. Kanski J., Aksenova M., Butterfield D.A. The hydrophobic environment of Met35 of Alzheimer's Aβ(1-42) is important for the neurotoxic and oxidative properties of the peptide. Neurotox. Res. 4:2002;219-223
27. Kuo Y.W., Kokjohn T.A., Beach T.G., Sue L.I., Brune D., Lopez J.C., et al. Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains. J. Biol. Chem. 276:2001;12991-12998
28. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA. 95:1998;6448-6453
29. Lauderback C.M., Hackett J.M., Huang F.F., Keller J.N., Szweda L.I., Markesbery W.R., et al. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: role of Aβ1-42. J. Neurochem. 78:2001;413-416
30. Lauderback C.M., Kanski J., Hackett J.M., Maeda N., Kindy M.S., Butterfield D.A. Apolipoprotein E modulates Alzheimer's Aβ(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner. Brain Res. 924:2002;90-97
31. Laws S.M., Hone E., Gandy S., Martins R.N. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J. Neurochem. 84:2003;1215-1236
32. Lovell M.A., Xie C., Markesbery W.R. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging. 22:2001;187-194
33. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1997;255-264
34. Markesbery W.R. Oxidative stress hypothesis in Alzheimer disease. Free Radic. Biol. Med. 23:1997;134-147
35. Markesbery W.R., Lovell M.A. 4-Hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging. 19:1998;33-36
36. Masliah E., Alford M., DeTeresa R., Mallory M., Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 40:1996;759-766
37. Naslund J., Schierhorn A., Hellman U., Lannfelt L., Roses A.D., Tjernberg L.O., et al. Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer's disease and normal aging. Proc. Natl. Acad. Sci. USA. 91:1994;8378-8382
38. Palmblad M., Westlind-Danielsson A., Bergquist J. Oxidation of methionine 35 attenuates formation of amyloid beta-peptide 1-40 oligomers. J. Biol. Chem. 277:2002;19506-19510
39. Pogocki D., Schoneich C. Redox properties of Met(35) in neurotoxic beta-amyloid peptide. A molecular modeling study. Chem. Res. Toxicol. 15:2002;408-418
40. Roses A.D. Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol. 53:1994;429-437
41. Shao H., Jao S.C., Ma K., Zagorski M.G. Solution structures of micelle-bound amyloid β-(1-40) and β-(1-42) peptides of Alzheimer's disease. J. Mol. Biol. 285:1999;755-773
42. Stadtman E.R., Moskovitz J., Berlett B.S., Levine R.L. Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism. Mol. Cell Biochem. 234:2002;3-9
43. Subramaniam R., Roediger F., Jordan B., Mattson M.P., Keller J.N., Waeg G., Butterfield D.A. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortial synaptosomal membrane proteins. J. Neurochem. 69:1997;1161-1169
44. Varadarajan S., Yatin S., Aksenova M., Butterfield D.A. Review: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 130:2000;184-208
45. Varadarajan S., Kanski J., Aksenova M., Lauderback C., Butterfield D.A. Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's Aβ(1-42) and Aβ(25-35). J. Am. Chem. Soc. 123:2001;5625-5631
46. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Condron M.M., Lomakin A., et al. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274:1999;25945-25952
47. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002;535-539
48. Yatin S.M., Link C.D., Butterfield D.A. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42). Neurobiol. Aging. 20:1999;325-330
49. Yatin S.M., Yatin M., Aulick T., Ain K.B., Butterfield D.A. Alzheimer's amyloid β-peptide generated free radicals increase rat embryonic neuronal polyamine uptake and ODC activity: protective effect of Vitamin E. Neurosci. Lett. 263:1999;17-20
50. Yatin S.M., Varadarajan S., Butterfield D.A. Vitamin E prevents Alzheimer's amyloid β-peptide (1-42)-induced protein oxidation and reactive oxygen species formation. J. Alzheimer's Dis. 2:2000;123-131